FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Reps Seek FDA Action on Drug Research in China

Four House Democrats and Republicans urge FDA to take a greater role in protecting U.S. national security interests that could be at risk when drug co...

latest-news-card-1
Human Drugs

Significant CGMP Violations at Eugia Pharma

FDA warns Indias Eugia Pharma Specialties about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

LDT Power Grab Suit Filed Against FDA

The Association for Molecular Pathology and a pathologist sue FDA to block implementation of the agencys final rule asserting regulatory authority ove...

latest-news-card-1
Human Drugs

Lillys Tirzepatide Curbs Progression to Diabetes

Eli Lilly says data from its SURMOUNT-1 study showed that tirzepatide contributed to significant weight loss and delayed in progression to diabetes in...

latest-news-card-1
Human Drugs

Post Timely De Novo Summaries: Law Firm

A Hyman, Phelps & McNamara medical device regulatory expert and attorney say FDA needs to improve the timeliness of its posting of de novo decision su...

latest-news-card-1
Medical Devices

ICU Medical Expands Class 1 Recall of Infusion Pumps

ICU Medical expands a Class 1 recall of its Plum 360, Plum A+ and Plum A+3 Infusion Systems to update the use instructions due to a manufacturing defe...

latest-news-card-1
Human Drugs

Transplant Drug Gets Orphan/Fast Track Status

FDA grants ReAlta Life Sciences orphan drug and fast track designations for RLS-0071 and its use in treating hospitalized patients with steroid-refrac...

latest-news-card-1
Human Drugs

Guide on ANDA Meeting Requests

FDA posts a final guidance entitled Product-Specific Guidance (PSG) Meetings Between FDA and ANDA Applicants Under GDUFA.

latest-news-card-1
Federal Register

Vaccines Panel to Discuss Pertussis Study Model

Federal Register notice: FDA announces a 9/20 Vaccines and Related Biological Products Advisory Committee to discuss controlled human infection models...

latest-news-card-1
Human Drugs

FDA Denies Petition Seeking to Block Liquidia NDA

FDA rejects a United Therapeutics citizen petition that asked it to withdraw tentative approval of a Liquidia Technologies NDA for Yutrepia (treprosti...